257 related articles for article (PubMed ID: 33136178)
21. [Diagnosis and management of paraneoplastic neurological syndromes].
Saji E; Kawachi I; Nishizawa M
Brain Nerve; 2010 Apr; 62(4):319-30. PubMed ID: 20420171
[TBL] [Abstract][Full Text] [Related]
22. Paraneoplastic antigens as biomarkers for early diagnosis of ovarian cancer.
Chatterjee M; Hurley LC; Tainsky MA
Gynecol Oncol Rep; 2017 Aug; 21():37-44. PubMed ID: 28653032
[TBL] [Abstract][Full Text] [Related]
23. [Paraneoplastic neurological syndrome and autoantibodies].
Hayashi Y; Inuzuka T
Brain Nerve; 2013 Apr; 65(4):385-93. PubMed ID: 23568986
[TBL] [Abstract][Full Text] [Related]
24. The associations between serum vascular endothelial growth factor, tumor necrosis factor and interleukin 4 with the markers of blood-brain barrier breakdown in patients with paraneoplastic neurological syndromes.
Michalak S; Kalinowska-Lyszczarz A; Rybacka-Mossakowska J; Zaborowski M; Kozubski W
J Neural Transm (Vienna); 2019 Feb; 126(2):149-158. PubMed ID: 30374596
[TBL] [Abstract][Full Text] [Related]
25. No evidence for circulating HuD-specific CD8+ T cells in patients with paraneoplastic neurological syndromes and Hu antibodies.
de Beukelaar JW; Verjans GM; van Norden Y; Milikan JC; Kraan J; Hooijkaas H; Sintnicolaas K; Gratama JW; Sillevis Smitt PA
Cancer Immunol Immunother; 2007 Sep; 56(9):1501-6. PubMed ID: 17597332
[TBL] [Abstract][Full Text] [Related]
26. Paraneoplastic neurological syndromes associated with ovarian tumors.
Zaborowski MP; Spaczynski M; Nowak-Markwitz E; Michalak S
J Cancer Res Clin Oncol; 2015 Jan; 141(1):99-108. PubMed ID: 24965744
[TBL] [Abstract][Full Text] [Related]
27. [Neurological syndromes, encephalitis].
Yamamoto T; Tsuji S
Gan To Kagaku Ryoho; 2010 Jun; 37(6):995-1005. PubMed ID: 20567100
[TBL] [Abstract][Full Text] [Related]
28. Prostate cancer, Hu antibodies and paraneoplastic neurological syndromes.
Storstein A; Raspotnig M; Vitaliani R; Giometto B; Graus F; Grisold W; Honnorat J; Vedeler CA
J Neurol; 2016 May; 263(5):1001-1007. PubMed ID: 27007485
[TBL] [Abstract][Full Text] [Related]
29. [Clinical characteristics of "classical" and "non-classical" paraneoplastic neurological syndrome].
Lyu XY; Wang GP; Tang QQ; Cheng ZZ; Gui W; Tian YH
Zhonghua Yi Xue Za Zhi; 2021 Mar; 101(9):615-619. PubMed ID: 33685041
[No Abstract] [Full Text] [Related]
30. Positivity of serum "classical" onconeural antibodies in a series of 2063 consecutive patients with suspicion of paraneoplastic neurological syndrome.
Gromadzka G; Karlińska AG; Łysiak Z; Błażejewska-Hyżorek B; Litwin T; Członkowska A
J Neuroimmunol; 2013 Jun; 259(1-2):75-80. PubMed ID: 23642452
[TBL] [Abstract][Full Text] [Related]
31. Onconeural antibodies are essential to diagnose paraneoplastic neurological syndromes.
Honnorat J
Acta Neurol Scand Suppl; 2006; 183():64-8. PubMed ID: 16637934
[TBL] [Abstract][Full Text] [Related]
32. Paraneoplastic neurological syndromes in patients affected by SCLC: a case series.
Zanella C; Leone AG; Zambelli L; Bottiglieri A; Canziani L; Brambilla M; Lo Russo G; Platania M; De Braud F; Occhipinti M
Tumori; 2022 Dec; 108(6):NP11-NP14. PubMed ID: 35260015
[TBL] [Abstract][Full Text] [Related]
33. Immunophenotypical characterization of paraneoplastic neurological syndrome patients: a multicentric study.
Lorusso L; Precone V; Hart IK; Giometto B; Pezzani R; Ngonga GK; Ngonga GKNK; Paolacci S; Ferrari D; Ricevuti G; Marshall E; Bertelli M
J Biosci; 2021; 46():. PubMed ID: 33709965
[TBL] [Abstract][Full Text] [Related]
34. Whole-body computed tomography as first-line imaging procedure to exclude cancer in patients with neurological suspicion of paraneoplastic syndromes: shall clinical practice adhere to recommendations?
Parillo M; Quattrocchi CC; Pilato F; Di Lazzaro V; Beomonte Zobel B
Radiography (Lond); 2023 Jan; 29(1):8-13. PubMed ID: 36179410
[TBL] [Abstract][Full Text] [Related]
35. Incidence and spectrum of paraneoplastic neurological syndromes: single center study.
Kanikannan MA; Sirisha Y; Uppin MS; Jabeen SA; Kandadai RM; Sundaram C; Raghunadharao D; Borgohain R
J Neurooncol; 2015 Oct; 125(1):197-206. PubMed ID: 26307447
[TBL] [Abstract][Full Text] [Related]
36. Cellular immune responses of older adults to four influenza vaccines: Results of a randomized, controlled comparison.
Kumar A; McElhaney JE; Walrond L; Cyr TD; Merani S; Kollmann TR; Halperin SA; Scheifele DW
Hum Vaccin Immunother; 2017 Sep; 13(9):2048-2057. PubMed ID: 28635557
[TBL] [Abstract][Full Text] [Related]
37. Paraneoplastic neurological syndrome due to burned-out testicular tumor showing hot cross-bun sign.
Ishikawa H; Kawada N; Taniguchi A; Odachi K; Mizutani A; Asahi M; Tomimoto H
Acta Neurol Scand; 2016 May; 133(5):398-402. PubMed ID: 26248690
[TBL] [Abstract][Full Text] [Related]
38. [Paraneoplastic neurological syndromes in 2008].
Honnorat J
Rev Neurol (Paris); 2009 May; 165 Suppl 3():S59-65. PubMed ID: 19524096
[TBL] [Abstract][Full Text] [Related]
39. Managing paraneoplastic neurological disorders.
de Beukelaar JW; Sillevis Smitt PA
Oncologist; 2006 Mar; 11(3):292-305. PubMed ID: 16549814
[TBL] [Abstract][Full Text] [Related]
40. The granzyme B and interferon-gamma enzyme-linked immunospot assay as alternatives for cytotoxic T-lymphocyte precursor frequency after renal transplantation.
van Besouw NM; Zuijderwijk JM; de Kuiper P; Ijzermans JN; Weimar W; van der Mast BJ
Transplantation; 2005 May; 79(9):1062-6. PubMed ID: 15880044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
